亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

會員登錄|免費注冊|忘記密碼|管理入口 返回主站||保存桌面|手機瀏覽|聯系方式|購物車
企業會員第1年

成都鈉鈳鋰生物科技有限公司  

自制標準品對照品,各類植物提取物

搜索
新聞中心
  • 暫無新聞
產品分類
  • 暫無分類
聯系方式
  • 聯系人:李曼
  • 電話:028-61983833
  • 郵件:cdnakeli@163.com
  • 微信:18000507060
  • QQ:1373789011
站內搜索
 
榮譽資質
  • 暫未上傳
友情鏈接
  • 暫無鏈接
首頁 > 供應產品 > 羌活醇 試劑 CAS:88206-46-6
羌活醇 試劑 CAS:88206-46-6
單價 面議對比
詢價 暫無
發貨 四川成都市付款后3天內
品牌 鈉鈳鋰
過期 長期有效
更新 2021-11-25 12:21
 
詳細信息

nkl-00262
中文名稱:羌活醇
英文名稱:Notopterol
英文別稱: 7 H-Furo[3,2-g][1]benzopyran-7-one, 4-[[(2E)-5-hydroxy-3,7-dimethyl-2,6-octadienyl]oxy]- (9CI); 4-[[(2E)-5-Hydroxy-3,7-dimethyl-2,6-octadien-1-yl]oxy]-7H-furo[3,2-g][1]benzopyran-7-one; 7H-Furo[3,2-g][1]benzopyran-7-one, 4-[(5-hydroxy-3,7-dimethyl-2,6-octadienyl)oxy]-, (E)-; Notopterol;7H-Furo[3,2-g][1]benzopyran-7-one, 4-[(5-hydroxy-3,7-dimethyl-2,6-octadienyl)oxy]-, (E)-(±)-
CAS號:88206-46-6
純度: HPLC≥98%

分子式:C21H22O5
分子量:354.40
外觀:無色結晶
沸點:546.7±50.0 °C | Condition: Press: 760 Torr
密度:1.216±0.06 g/cm3 |條件:溫度:20°C
PKA:14.63±0.20 | Condition: Most Acidic Temp: 25 °C
旋光度:0°(c=1.99,氯仿)
規格: 20mg 50mg 100mg 500mg g級等應客戶需求包裝.
提取來源:傘形科羌活 Notopterygium forbesii Boiss.地下部分
藥理藥效:鎮痛作用,鎮靜作用,抗炎作用。
儲存條件: 2-8°C,避光、干燥、密封

用途: 用于鑒別、含量測定、藥理實驗、活性篩選等科研、實驗室使用;不得用于注射、食用或其他

供應商:成都鈉鈳鋰生物科技有限公司 1

©2025 成都鈉鈳鋰生物科技有限公司 版權所有   技術支持:化工網   訪問量:21348  
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |